HHS

SSPs aren’t thrilled by TTD characterizing them as “resellers”; Amazon DSP just announced a new partnership to sell Netflix inventory; and pharma brands will be subject to stricter regulations, per the FDA.

The odds of RFK Jr. implementing a ban on TV drug ads are slim, says our guest this week, BranchLab’s Josh Walsh. Still, pharma advertisers could face other regulatory changes over the next four years. Plus: We break down Forrester’s picks for the top 10 SSPs.